{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:52:10Z","timestamp":1774659130781,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00259-005-0013-2","type":"journal-article","created":{"date-parts":[[2006,1,31]],"date-time":"2006-01-31T13:35:29Z","timestamp":1138714529000},"page":"595-601","source":"Crossref","is-referenced-by-count":60,"title":["First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent"],"prefix":"10.1007","volume":"33","author":[{"given":"Yicheng","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Huyghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"de Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Nuyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Mortelmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfons M.","family":"Verbruggen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy M.","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,1]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-003-1136-y","volume":"30","author":"A Flotats","year":"2003","unstructured":"Flotats A, Carri\u00f3 I. Non-invasive in vivo imaging of myocardial apoptosis and necrosis. Eur J Nucl Med Mol Imaging 2003;30:615\u2013630","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13_CR2","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI108825","volume":"60","author":"LM Buja","year":"1977","unstructured":"Buja LM, Tofe AJ, Kulkarni PV, Mukherjee A, Parkey RW, Francis MD, et al. Sites and mechanisms of localization of technetium-99m phosphorous radiopharmaceuticals in acute myocardial infarcts and other tissues. J Clin Invest 1977;60:724\u2013740","journal-title":"J Clin Invest"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/01.CIR.74.3.501","volume":"74","author":"BA Khaw","year":"1986","unstructured":"Khaw BA, Gold HK, Yasuda T, Leinbach RC, Kanke M, Fallon JT, et al. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of cardiac myosin specific antibody. Circulation 1986;74:501\u2013508","journal-title":"Circulation"},{"key":"13_CR4","first-page":"1671","volume":"28","author":"BA Khaw","year":"1987","unstructured":"Khaw BA, Yasuda T, Gold HK, Leinbach RC, Johns JA, Kanke M, et al. Acute myocardial infarction imaging with indium-111 labeled monoclonal antimyosin Fab fragments. J Nucl Med 1987;28:1671\u20131678","journal-title":"J Nucl Med"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/01.CIR.60.7.1527","volume":"60","author":"BA Khaw","year":"1979","unstructured":"Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies. Circulation 1979;60:1527\u20131531","journal-title":"Circulation"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1126\/science.7051286","volume":"217","author":"BA Khaw","year":"1982","unstructured":"Khaw BA, Scott J, Fallon JT, Cahill SL, Haber E, Homcy C. Myocardial injury: quantitation by cell sorting initiated with antimyosin fluorescent spheres. Science 1982;217:1050\u20131053","journal-title":"Science"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0001-2998(99)80014-2","volume":"29","author":"BA Khaw","year":"1999","unstructured":"Khaw BA. The current role of infarct avid imaging. Semin Nucl Med 1999;29:259\u2013270","journal-title":"Semin Nucl Med"},{"key":"13_CR8","first-page":"81","volume":"76","author":"W Frist","year":"1987","unstructured":"Frist W, Yasuda T, Segall G, Khaw BA, Strauss HW, Gold H, et al. Noninvasive detection of human cardiac transplant rejection with indium-111 anti-myosin (Fab) imaging. Circulation 1987;76:81\u201385","journal-title":"Circulation"},{"key":"13_CR9","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/01.CIR.82.6.2100","volume":"82","author":"M Ballester","year":"1990","unstructured":"Ballester M, Obrador D, Carrio I, Auge JM, Moya C, Ponsllado G, et al. 111In-monoclonal antimyosin antibody studies after the first year of heart transplantation: identification of risk groups for developing rejection during long-term follow-up and clinical implications. Circulation 1990;82:2100\u20132108","journal-title":"Circulation"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00006231-200209000-00011","volume":"23","author":"RAV Olmos","year":"2002","unstructured":"Olmos RAV, Carrio I, Hoefnagel CA, Estorch M, Huinink WWT, Lopez-Pousa J, et al. High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction. Nucl Med Commun 2002;23:871\u2013877","journal-title":"Nucl Med Commun"},{"key":"13_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0735-1097(90)90463-Y","volume":"6","author":"GW Dec","year":"1990","unstructured":"Dec GW, Palacios IF, Yasuda T, Fallon JT, Khaw BA, Strauss HW, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Coll Cardiol 1990;6:97\u2013104","journal-title":"J Am Coll Cardiol"},{"key":"13_CR12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1056\/NEJM199301143280205","volume":"328","author":"J Narula","year":"1992","unstructured":"Narula J, Khaw BA, Dec GW, Palacios IF, Southern JF, Fallon JT, et al. Recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med 1992;328:100\u2013104","journal-title":"N Engl J Med"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0735-1097(93)90385-E","volume":"21","author":"D Obrador","year":"1993","unstructured":"Obrador D, Ballester M, Carrio I, Auge JM, Lopez CM, Bosch I, et al. Active myocardial damage without attending inflammatory response in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1993;21:1667\u20131671","journal-title":"J Am Coll Cardiol"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.89.5.2054","volume":"89","author":"D Obrador","year":"1994","unstructured":"Obrador D, Ballester M, Carri\u00f3 I, Moya C, Bosch I, Marti V, et al. Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies. Circulation 1994;89:2054\u20132061","journal-title":"Circulation"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/01.CIR.95.6.1577","volume":"95","author":"J Narula","year":"1995","unstructured":"Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labeled glucarate. Circulation 1995;95:1577\u20131584","journal-title":"Circulation"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1071-3581(97)90105-7","volume":"4","author":"BA Khaw","year":"1997","unstructured":"Khaw BA, Nakazama A, O\u2019Donell SM, Pak KY, Narula J. Avidity of technetium-99m glucarate for the necrotic myocardium: in vivo and in vitro assessment. J Nucl Cardiol 1997;4:283\u2013290","journal-title":"J Nucl Cardiol"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/00004424-199009001-00034","volume":"25","author":"J Nelson","year":"1990","unstructured":"Nelson J, Schmiedl U, Shankland E. Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. Invest Radiol 1990;25:S71\u2013S73","journal-title":"Invest Radiol"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1076-6332(05)80437-4","volume":"2","author":"Y Ni","year":"1995","unstructured":"Ni Y, Marchal G, Yu J, Lukito G, Petre C, Wevers M, et al. Localization of metalloporphyrin induced \u201cspecific\u201d enhancement in experimental liver tumors: a comparison between MRI, microangiographic and histologic findings. Acad Radiol 1995;2:687\u2013699","journal-title":"Acad Radiol"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00004424-199712000-00008","volume":"32","author":"Y Ni","year":"1997","unstructured":"Ni Y, Petr\u00e9 C, Miao Y, Yu J, Cresens E, Adriaens P, et al. Magnetic resonance imaging\u2013histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis. Invest Radiol 1997;32:770\u2013779","journal-title":"Invest Radiol"},{"key":"13_CR20","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00008390-200010010-00006","volume":"10","author":"J Maurer","year":"2000","unstructured":"Maurer J, Strauss A, Ebert W, Bauer H, Felix R. Contrast-enhanced high resolution magnetic resonance imaging of pigmented malignant melanoma using Mn-TPPS4 and Gd-DTPA: experimental results. Melanoma Res 2000;10:40\u201346","journal-title":"Melanoma Res"},{"key":"13_CR21","unstructured":"Marchal G, Ni Y. Use of porphyrin-complex or expanded porphyrin-complex as an infarction localization diagnosticum. U.S. patent No. 6,013,241. 11 January 2000"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/BF00619942","volume":"6","author":"G Marchal","year":"1996","unstructured":"Marchal G, Ni Y, Herijgers P, Flameng W, Petre C, Bosmans H, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by magnetic resonance imaging. Eur Radiol 1996;6:2\u20138","journal-title":"Eur Radiol"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"S395","DOI":"10.1016\/S1076-6332(96)80595-2","volume":"3","author":"Y Ni","year":"1996","unstructured":"Ni Y, Marchal G, Herijgers P, Flameng W, Petre C, Ebert W, et al. Paramagnetic metalloporphyrins: from enhancers for malignant tumors to markers of myocardial infarcts. Acad Radiol 1996;3:S395\u2013S377","journal-title":"Acad Radiol"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1023\/A:1005715426172","volume":"13","author":"P Herijgers","year":"1997","unstructured":"Herijgers P, Laycock SK, Ni Y, Marchal G, Bogaert J, Bosmans H, et al. Localization and determination of infarct size by Gd-mesoporphyrin enhanced MRI in dogs. Int J Cardiac Imaging 1997;13:499\u2013507","journal-title":"Int J Cardiac Imaging"},{"key":"13_CR25","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1076-6332(98)80053-6","volume":"5","author":"Y Ni","year":"1998","unstructured":"Ni Y, Pislaru C, Bosmans H, Pislaru S, Miao Y, Van de Werf F, et al. Validation of intracoronary delivery of metalloporphyrin as an in vivo \u201chistochemical staining\u201d for myocardial infarction with MR imaging. Acad Radiol 1998;5:S37\u201341","journal-title":"Acad Radiol"},{"key":"13_CR26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0033-8389(05)70099-3","volume":"37","author":"AE Stillman","year":"1999","unstructured":"Stillman AE, Wilke N, Jerosch-Herold M. Myocardial viability. Radiol Clin North Am 1999;37:361","journal-title":"Radiol Clin North Am"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.99.5.690","volume":"99","author":"SV Pislaru","year":"1999","unstructured":"Pislaru SV, Ni Y, Pislaru C, Bosmans H, Miao Y, Bogaert J, et al. Noninvasive measurements of infarct size after thrombolysis with a necrosis-avid MRI contrast agent. Circulation 1999;99:690\u2013696","journal-title":"Circulation"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1148\/radiology.213.1.r99se30247","volume":"213","author":"M Saeed","year":"1999","unstructured":"Saeed M, Bremerich J, Wendland MF, Wyttenbach R, Weinmann HJ, Higgins CB. Reperfused myocardial infarction as seen with use of necrosis-specific versus standard extracellular MR contrast media in rats. Radiology 1999;213:247\u201357","journal-title":"Radiology"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/(SICI)1522-2586(199911)10:5<686::AID-JMRI11>3.0.CO;2-H","volume":"10","author":"TH Lim","year":"1999","unstructured":"Lim TH, Choi SI. MRI of myocardial infarction. J Magn Reson Imaging 1999;10:686\u2013693","journal-title":"J Magn Reson Imaging"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/(SICI)1522-2586(199911)10:5<694::AID-JMRI12>3.0.CO;2-J","volume":"10","author":"MF Wendland","year":"1999","unstructured":"Wendland MF, Saeed M, Lund G, Higgins CB. Contrast-enhanced MRI for quantification of myocardial viability. J Magn Reson Imaging 1999;10:694\u2013702","journal-title":"J Magn Reson Imaging"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1148\/radiology.215.3.r00jn01863","volume":"215","author":"SI Choi","year":"2000","unstructured":"Choi SI, Choi SH, Kim ST, Lim KH, Lim CH, Gong GY, et al. Irreversibly damaged myocardium at MR imaging with a necrotic tissue-specific contrast agent in a cat model. Radiology 2000;215:863\u2013868","journal-title":"Radiology"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiol.2263011473","volume":"226","author":"SS Lee","year":"2003","unstructured":"Lee SS, Goo HW, Park SB, Lim CH, Gong GY, Seo LB, et al. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model. Radiology 2003;226:739\u2013747","journal-title":"Radiology"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1148\/radiology.205.2.9356609","volume":"205","author":"Y Ni","year":"1997","unstructured":"Ni Y, Miao Y, Bosmans H, Marchal GJ, Semmler W, Baert AL. Evaluation of interventional liver tumor ablation with Gd-mesoporphyrin enhanced magnetic resonance imaging. Radiology 1997;205:P319","journal-title":"Radiology"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnci\/85.6.443","volume":"85","author":"HI Pass","year":"1993","unstructured":"Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443\u2013456","journal-title":"J Natl Cancer Inst"},{"key":"13_CR35","first-page":"737","volume":"18","author":"B Chen","year":"2001","unstructured":"Chen B, Zupko I, De Witte PA. Photodynamic therapy with hypericin in a mouse P388 tumor model: vascular effects determine the efficacy. Int J Oncol 2001;18:737\u2013742","journal-title":"Int J Oncol"},{"key":"13_CR36","doi-asserted-by":"crossref","first-page":"S965","DOI":"10.1002\/jlcr.25804401339","volume":"44","author":"H Vanbilloen","year":"2001","unstructured":"Vanbilloen H, Bormans G, Chen B, de Witte P, Verbruggen A, Verbeke K. Synthesis and preliminary evaluation of mono-[123I]iodohypericin. J Labelled Compd Radiopharm 2001;44:S965\u2013967","journal-title":"J Labelled Compd Radiopharm"},{"key":"13_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004424-200102000-00005","volume":"36","author":"Y Ni","year":"2001","unstructured":"Ni Y, Adzamli K, Miao Y, Cresens E, Yu J, Periasamy MP, et al. MRI contrast enhancement of necrosis by MP-2269 and Gadophrin-2 in a rat model of liver infarction. Invest Radiol 2001;36:97\u2013103","journal-title":"Invest Radiol"},{"key":"13_CR38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1148\/radiol.2252020113","volume":"225","author":"Y Ni","year":"2002","unstructured":"Ni Y, Dymarkowski S, Chen F, Bogaert J, Marchal G. Occlusive myocardial infarction: enhanced or not enhanced with necrosis avid contrast agents at magnetic resonance imaging. Radiology 2002;225:603\u2013605","journal-title":"Radiology"},{"key":"13_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/01.CIR.56.2.146","volume":"56","author":"R Rude","year":"1977","unstructured":"Rude R, Parkey RW, Bonte FJ, Twieg D, Lewis S, Pulido J, et al. Clinical implications of the \u201cdoughnut\u201d pattern of uptake in myocardial imaging with technetium-99m stannous pyrophosphate. Circulation 1977;56:146","journal-title":"Circulation"},{"key":"13_CR40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/med.2610150203","volume":"15","author":"G Lavie","year":"1995","unstructured":"Lavie G, Mazur Y, Lavie D, Meruelo D. The chemical and biological properties of hypericin: a compound with a broad spectrum of biological activities. Med Res Rev 1995;15:111\u2013119","journal-title":"Med Res Rev"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-0013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-005-0013-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-005-0013-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T15:58:48Z","timestamp":1558713528000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-005-0013-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s00259-005-0013-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,1]]}}}